Literature DB >> 25604161

Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine.

C Hochfellner1, D Evangelopoulos, M Zloh, A Wube, J D Guzman, T D McHugh, O Kunert, S Bhakta, F Bucar.   

Abstract

AIMS: The interaction of quinolone and indoloquinazoline alkaloids concerning their antimycobacterial activity was studied. METHODS AND
RESULTS: The antimycobacterial and modulating activity of evodiamine (1), rutaecarpine (2) and evocarpine (3) was tested on mycobacteria including three multidrug-resistant (MDR) clinical isolates of Mycobacterium tuberculosis. Antagonistic effects were concluded from fractional inhibitory concentration (FICI) values. Interaction energies of the compounds were calculated using GLUE docking module implemented in GRID. 1 and 2 exhibited weak inhibition of rapidly growing mycobacteria, however, 1 was active against Myco. tuberculosis H37Rv (MIC = 10 mg l(-1) ) while 2 was inactive. Both 1 and 2 showed a marked antagonistic effect on the susceptibility of different mycobacterial strains to 3 giving FICI values between 5 and 9. The interaction energies between compounds 1 and 2 with compound 3 suggested the possibility of complex formation in solution.
CONCLUSIONS: Indoloquinazoline alkaloids markedly reduce the antimycobacterial effect of the quinolone alkaloid evocarpine. Complex formation may play a role in the attenuation of its antimycobacterial activity. SIGNIFICANCE AND IMPACT OF THE STUDY: This study gives a striking example of antagonism between compounds present in the same plant extract which should be considered in natural product based screening projects.
© 2015 The Society for Applied Microbiology.

Entities:  

Keywords:  Euodia; antagonism; evocarpine; evodiamine; modelling; mycobacteria; rutaecarpine

Mesh:

Substances:

Year:  2015        PMID: 25604161     DOI: 10.1111/jam.12753

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

1.  Investigation of Copaifera genus as a new source of antimycobaterial agents.

Authors:  Jéssica Aparecida Alves; Fariza Abrão; Thaís da Silva Moraes; Jaqueline Lopes Damasceno; Marcos Fernando Dos Santos Moraes; Rodrigo Cassio Sola Veneziani; Sérgio Ricardo Ambrósio; Jairo Kenupp Bastos; Mayker Lázaro Dantas Miranda; Carlos Henrique Gomes Martins
Journal:  Future Sci OA       Date:  2020-05-29

2.  Synthesis and in vitro evaluation of antitumor activity of spiro[indolo[2,1-b]quinazoline-pyrano[2,3-d]pyrimidine] and spiro[indolo[2,1-b]quinazoline-pyrido[2,3-d]pyrimidine] derivatives by using 2D and 3D cell culture models.

Authors:  Zahra Sadeghian; Mohammad Bayat; Fatemeh Safari
Journal:  Mol Divers       Date:  2022-01-19       Impact factor: 2.943

Review 3.  Review on plant antimicrobials: a mechanistic viewpoint.

Authors:  Bahman Khameneh; Milad Iranshahy; Vahid Soheili; Bibi Sedigheh Fazly Bazzaz
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-16       Impact factor: 4.887

Review 4.  Plant Secondary Metabolites in the Battle of Drugs and Drug-Resistant Bacteria: New Heroes or Worse Clones of Antibiotics?

Authors:  Cyrill L Gorlenko; Herman Yu Kiselev; Elena V Budanova; Andrey A Zamyatnin; Larisa N Ikryannikova
Journal:  Antibiotics (Basel)       Date:  2020-04-10

Review 5.  Naturally-Occurring Alkaloids of Plant Origin as Potential Antimicrobials against Antibiotic-Resistant Infections.

Authors:  Bruno Casciaro; Laura Mangiardi; Floriana Cappiello; Isabella Romeo; Maria Rosa Loffredo; Antonia Iazzetti; Andrea Calcaterra; Antonella Goggiamani; Francesca Ghirga; Maria Luisa Mangoni; Bruno Botta; Deborah Quaglio
Journal:  Molecules       Date:  2020-08-09       Impact factor: 4.411

6.  Synthesis of indolo[1,2-c]quinazolines from 2-alkynylaniline derivatives through Pd-catalyzed indole formation/cyclization with N,N-dimethylformamide dimethyl acetal.

Authors:  Antonio Arcadi; Sandro Cacchi; Giancarlo Fabrizi; Francesca Ghirga; Antonella Goggiamani; Antonia Iazzetti; Fabio Marinelli
Journal:  Beilstein J Org Chem       Date:  2018-09-14       Impact factor: 2.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.